Your browser doesn't support javascript.
loading
Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?
Perego, Gianluca; Nozza, Renata; Oggionni, Emanuela; Cabiddu, Mary; Scolari, Cinzia; Omati, Elena; Castelli, Emanuela A; Petrelli, Fausto.
Afiliação
  • Perego G; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy.
  • Nozza R; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy.
  • Oggionni E; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy.
  • Cabiddu M; Oncology Unit, Asst Bergamo Ovest, Treviglio (BG), Italy.
  • Scolari C; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy.
  • Omati E; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy.
  • Castelli EA; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy.
  • Petrelli F; Pharmacy Unit, ASST Bergamo Ovest, Treviglio (BG), Italy.
J Oncol Pharm Pract ; 26(4): 967-971, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32041467

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas / Piperazinas / Antineoplásicos Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas / Piperazinas / Antineoplásicos Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article